🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to assess the effect of selpercatinib on ...
Status
Completed
Location
Celerion
Start Date
2018-07-12
Trial ID
NCT05338476
Treatments Being Tested
The reason for this study is to see if the study drug selpercatinib is safe...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-02-11
Trial ID
NCT04211337
Treatments Being Tested
This research is being done to determine the efficacy of selpercatinib to r...
Status
Recruiting
Location
MedStar Washington Hospital Center
Start Date
2023-03-01
Trial ID
NCT05668962
Treatments Being Tested
This phase II LUNG-MAP treatment trial studies how well selpercatinib works...
Status
Active Not Recruiting
Location
Fairbanks Memorial Hospital
Start Date
2020-04-08
Trial ID
NCT04268550
Treatments Being Tested
IMPRESS-Norway is a prospective, non-randomized clinical trial evaluating e...
Status
Recruiting
Location
Sykehuset Ålesund
Start Date
2021-04-01
Trial ID
NCT04817956
Treatments Being Tested
Phase 2 Platform Study in Patients with Advanced Non-Small Lung Cancer who ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-06-25
Trial ID
NCT03944772
The reason for this study is to see if the study drug, selpercatinib, compa...
Status
Active Not Recruiting
Location
UCLA Hematology/Oncology - Santa Monica
Start Date
2021-12-20
Trial ID
NCT04819100
Treatments Being Tested
This is an open-label, first-in-human study designed to evaluate the safety...
Status
Active Not Recruiting
Location
Mayo Clinic of Scottsdale
Start Date
2017-05-02
Trial ID
NCT03157128
Treatments Being Tested
The main purpose of this study is to determine how safe and how well tolera...
Status
Completed
Location
Celerion
Start Date
2019-02-12
Trial ID
NCT05338515
Treatments Being Tested
The main purpose of this study is to determine the effect of selpercatinib ...
Status
Completed
Location
Labcorp Clinical Research LP
Start Date
2023-07-27
Trial ID
NCT05906836
Treatments Being Tested